Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kyoko Inadomi"'
Publikováno v:
Case Reports in Medicine, Vol 2014 (2014)
Precursor T lymphoblastic lymphoma (T-LBL) often manifests as a mediastinal mass sometimes compressing vital structures like vessels or large airways. This case was a 40-year-old male who developed T-LBL presenting as respiratory failure caused by me
Externí odkaz:
https://doaj.org/article/a943660145f44ab7938888bc9f8b45bc
Autor:
Hitoshi Kusaba, Kenta Nio, Koichi Akashi, Kyoko Inadomi, Michitaka Nakano, Mamoru Ito, Yuta Okumura, Hiroshi Ariyama, Shuji Arita, Kenichi Kohashi, Eishi Baba, Nobuhiro Tsuruta, Kosuke Sagara, Tomoyasu Yoshihiro, Kenji Tsuchihashi, Yoshinao Oda, Fumiyasu Hanamura
Publikováno v:
Molecular and Clinical Oncology
Pancreatic acinar cell carcinoma (PACC) is a rare tumor of the exocrine pancreas, representing only 1% of all pancreatic malignancies. A 50-year-old man presented with edema of the thumb joints bilaterally, followed by an appearance of masses in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64e81bd9e997084dc654124a6a199e8
http://europepmc.org/articles/PMC5451886
http://europepmc.org/articles/PMC5451886
Autor:
KYOKO INADOMI1, HOZUMI KUMAGAI1, KOTOE TAKAYOSHI1, HIROSHI ARIYAMA1, HITOSHI KUSABA1, AKIHIRO NISHIE2, HIDETAKA YAMAMOTO3, KEN TAKASE4, MAMORU TANAKA1, KOSUKE SAGARA1, YUTA OKUMURA1, KENTA NIO1, MICHITAKA NAKANO1, SHUJI ARITA1, YOSHINAO ODA3, KOICHI AKASHI1, EISHI BABA5 e-baba@intmed1.med.kyushu-u.ac.jp
Publikováno v:
Oncology Letters. Nov2015, Vol. 10 Issue 5, p2981-2985. 5p.
Autor:
Kyoko Inadomi, Yasuo Mori, Katsuto Takenaka, Kensuke Sasaki, Teppei Sakoda, Kenjiro Kamezaki, Koichi Akashi, Toshihiro Miyamoto, Takahiro Maeda, Koji Kato, Hiromi Iwasaki, Goichi Yoshimoto
Publikováno v:
Leukemia & Lymphoma. 59:2005-2007
Successful sequential hematopoietic stem cell transplantation (HSCT) following liver transplantation (LT) has been reported in some cases, most often in children, in whom severe aplastic anemia (SA...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4f5a8a5d9207ec2490dab75dc66451f
https://doi.org/10.1080/10428194.2017.1403021
https://doi.org/10.1080/10428194.2017.1403021
Autor:
Kenji Mitsugi, Takeharu Yamanaka, Koichi Akashi, Akitaka Makiyama, Hitoshi Kusaba, Chinatsu Makiyama, Kotoe Takayoshi, Kenta Nio, Eishi Baba, Hozumi Kumagai, Yoshihiro Shibata, Tsuyoshi Shirakawa, Hiroshi Ariyama, Taito Esaki, Kyoko Inadomi, Shingo Tamura, Mamoru Ito, Gen Hirano
Publikováno v:
Medicine
Purpose: Combination therapy of fosaprepitant, dexamethasone (DEX) and a serotonin (5-HT3) receptor antagonist is a standard antiemetic prophylaxis for patients receiving highly emetogenic chemotherapy (HEC). However, the appropriate dose of DEX has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eb60bed1f6b7372c953ffa9c88c26a
http://europepmc.org/articles/PMC6023705
http://europepmc.org/articles/PMC6023705
Autor:
Masato Komoda, Yuzo Matsushita, Kyoko Inadomi, Kohei Arimizu, Keita Uchino, Tsuyoshi Shirakawa, Hiroshi Ariyama, Akitaka Makiyama, Yudai Shinohara, Tatsuhiro Kajitani, Taito Esaki, Hirofumi Ohmura, Hisanobu Oda, Koichi Akashi, Hitoshi Kusaba, Miyuki Kuwayama, Shuji Arita, Chinatsu Makiyama, Eishi Baba, Gen Hirano
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 21(3)
Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinoteca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848965fd8036211ab2ee07403397f1cd
https://pubmed.ncbi.nlm.nih.gov/28799048
https://pubmed.ncbi.nlm.nih.gov/28799048
Autor:
Kenji Tsuchihashi, Akitaka Makiyama, Yoshihiro Shibata, Yudai Shinohara, Chinatsu Makiyama, Shuji Arita, Eishi Baba, Kenji Mitsugi, Taito Esaki, Kyoko Inadomi, Koichi Akashi, Keita Uchino, Tsuyoshi Shirakawa, Hiroshi Ariyama, Hitoshi Kusaba, Kotoe Takayoshi, Masato Uenomachi
Publikováno v:
Cancer chemotherapy and pharmacology. 80(2)
Standard therapy for advanced small bowel adenocarcinoma (SBA) has not yet been established. The present study assessed the efficacy and safety of chemotherapy (CT) in association with molecular targeting approaches for SBA. The histories of 33 advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231b7b09596863e4e975730b868d9728
https://pubmed.ncbi.nlm.nih.gov/28653251
https://pubmed.ncbi.nlm.nih.gov/28653251
Autor:
Kohei Arimizu, Taito Esaki, Hirofumi Ohmura, Kenji Mitsugi, Hiroshi Ariyama, Risa Tanaka, Koichi Akashi, Keita Uchino, Eishi Baba, Yuzo Matsushita, Yoshihiro Shibata, Gen Hirano, Miyuki Kuwayama, Kyoko Inadomi, Fumiyasu Hanamura, Shuji Arita, Akitaka Makiyama, Hitoshi Kusaba, Kotoe Takayoshi
Publikováno v:
Anticancer research. 37(5)
Background Significant efficacy of oxaliplatin-based chemotherapy has been demonstrated for advanced gastric cancer (AGC). However, the appropriate dose of oxaliplatin, and the efficacy and toxicity of administration of oxaliplatin subsequent to cisp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d086598f2772291bd865485e53b0999
https://pubmed.ncbi.nlm.nih.gov/28476842
https://pubmed.ncbi.nlm.nih.gov/28476842
Autor:
Yuichi Yamada, Michitaka Nakano, Tomoyasu Yoshihiro, Hozumi Shimokawa, Kyoko Inadomi, Hitoshi Kusaba, Masato Komoda, Kenichi Kohashi, Fumiyasu Hanamura, Keita Uchino, Mamoru Ito, Yoshinao Oda, Eishi Baba, Shuji Arita, Nobuhiro Tsuruta, Ryuji Tominaga, Kenji Tsuchihashi, Koichi Akashi, Kosuke Sagara, Yuta Okumura, Kenta Nio, Hiroshi Ariyama
Publikováno v:
Molecular and Clinical Oncology
Dermatofibrosarcoma protuberans (DFSP) is a locally invading tumor, characterized by the presence of the collagen type I α 1 (COL1A1)-platelet-derived growth factor (PDGF) β fusion gene. We herein report the case of a 31-year-old man with a history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3ad205337058f759f631c554938e3e
https://pubmed.ncbi.nlm.nih.gov/28515919
https://pubmed.ncbi.nlm.nih.gov/28515919
Autor:
Kyoko Inadomi, Tomoya Matsunobu, Hozumi Kumagai, Katsumi Harimaya, Eishi Baba, Hitoshi Kusaba, Kotoe Takayoshi, Hiroshi Ariyama, Koichi Akashi, Shuji Arita
Publikováno v:
Medicine
Appropriate antiemetic prophylaxis for moderately emetogenic chemotherapy in patients with non-round cell soft-tissue sarcomas (NRC-STS) remains unclear. We retrospectively investigated efficacy and safety of aprepitant-combined antiemetic prophylaxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a77841b9893a469821dfa7ff13514eb
https://pubmed.ncbi.nlm.nih.gov/27930525
https://pubmed.ncbi.nlm.nih.gov/27930525